首页> 外文期刊>Muscle and Nerve >Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT). Tolrestat Study Group For Edit (Early Diabetes Intervention Trial)
【24h】

Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT). Tolrestat Study Group For Edit (Early Diabetes Intervention Trial)

机译:早期糖尿病干预试验(EDIT)中轻度糖尿病性神经病患者的中位单神经病发生率。 Tolrestat研究小组进行编辑(早期糖尿病干预试验)

获取原文
获取原文并翻译 | 示例
           

摘要

We used electrophysiologic criteria to identify median mononeuropathy (MM) at the nondominant wrist among 414 patients enrolled in a multicenter study of patients with mild diabetic neuropathy according to consensus recommendations. Patients with absent sural or peroneal responses or greater than mild symptoms of carpal tunnel syndrome were ineligible. Ninety-five of 414 participants (23%) fulfilled criteria for MM, independent of diabetes type. Patients with MM had a longer duration of diabetes than remaining patients, independent of age, and patients with MM and type II diabetes were more likely to be female (34% vs. 19%; P = 0.008), shorter (165.7 vs. 172.7 cm; P = 0.001), and have a higher body mass index (32.5 vs. 29.1; P = 0.0008) than remaining type II patients. Sural or peroneal conduction abnormalities did not influence the frequency of MM. These results suggest that patients with diabetic neuropathy require special consideration with regard to the evaluation of suspected carpel tunnel syndrome.
机译:根据共识建议,我们使用电生理学标准在参与轻度糖尿病性神经病患者的多中心研究的414例患者中,确定非优势腕部的中位性单神经病(MM)。没有腓肠肌或腓骨反应或腕管综合症症状轻微的患者是不合格的。 414名参与者中有95名(23%)符合MM标准,与糖尿病类型无关。 MM患者的糖尿病持续时间比其余患者更长,不受年龄的影响,并且MM和II型糖尿病患者更有可能是女性(34%比19%; P = 0.008),较短(165.7比172.7)厘米; P = 0.001),并且比其余的II型患者有更高的体重指数(32.5对29.1; P = 0.0008)。神经或腓骨传导异常不影响MM的发生频率。这些结果表明,患有糖尿病性神经病的患者在评估可疑心管综合征时需要特别考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号